Pilot Study to Determine Safety and Efficacy of Orbital Injections of LIPO-102 in Patients With Symptomatic Exophthalmos Associated With Thyroid-related Eye Disease (TED)

NCT00954057 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

11

Enrollment

INDUSTRY

Sponsor class

Conditions

Thyroid-Related Eye Disease

Interventions

DRUG: LIPO-102
DRUG: Placebo

Sponsor

Neothetics, Inc